Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results and Investor Webinar

26 Jan 2024 07:00

RNS Number : 9670A
Accrol Group Holdings PLC
26 January 2024
 

 

26 January 2024

Accrol Group Holdings plc

("Accrol, or the "Group")

 

Notice of Half Year Results and Investor Webinar

 

Accrol (AIM: ACRL), the UK's leading independent tissue converter, will release its Half Year Results for the six months to 31 October 2023 on Tuesday 30 January 2024.

 

As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Friday, 2 February 2024 at 1.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_H124_results_webinar.

 

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Chris Welsh, Chief Financial Officer

 

Zeus (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre/ Mark Percy / James Thomas / Isobel Jones

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK.

 

For more information, please visit www.accrol.co.uk.

 

Link for Accrol Today video: https://www.accrol.co.uk/our-business/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORBRGDBGGDDGSU
Date   Source Headline
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.